News Archive

The rise of corporate venture capital investors, whether at the seed-stage, in the largest financings or into the billion-dollar valuation club, has been reshaping the VC ecosystem as of late. And while some VCs including Fred Wilson have been critical of corporate venture units, others have syndicated dozens of deals with corporate venture arms in just the past few years alone.

Using CB Insights data, we took a look at which VC firms have co-invested in the highest number of deals with a corporate venture unit since 2008 and how their CVC-syndicated deals added up as a percentage of their overall deal activity.

Leaders from 3D printing, fab labs and laser technologies will participate in a Digital Fabrication Summit to open the new Potomac Digital Fabrication Center at BWTech@UMBC in Baltimore, Maryland (US). The event will be held on 6 May 2014 and is being organised by Potomac Photonics, Inc. in cooperation with the non-profit FabLab Hub. The summit will bring together visionaries who are leading the next industrial revolution.

Avi Reichental, chief executive officer (CEO) of 3D Systems Corporation, will deliver the keynote, “Manufacturing the Future.” 3D Systems has been at the forefront of digital fabrication since company founder Chuck Hull invented stereo-lithography in 1983. Reichental has been one of those responsible for the dramatic shift from a technology for specialised applications to tools for mainstream markets. Potomac is an authorised 3D Systems equipment reseller and service provider and is creating a 3D printing equipment showcase in the new facility.

The exuberance of last year’s  record D.C. region venture totals waned somewhat in the first three months of 2014, with 43 companies raising a collective $217.5 million, according to the MoneyTree report released Friday by PricewaterhouseCoopers and the National Venture Capital Association.

The total represents an 18 percent drop compared with the same period last year, and a 31 percent fall from the fourth quarter of 2013.

Today Healthbox announces it has closed $7 million in funding to expand on its accelerator model and launch three new business verticals that will continue to drive actionable innovation through collaboration between entrepreneurs and the healthcare industry.

This is a bold vision for a healthcare accelerator. Healthbox closed the $7 million from a collaborative group of leading healthcare organizations to form Healthbox Global Partners, LLC, representing the common need to find and implement transformative solutions that will improve health outcomes.

In the winter of 1996, as part of my new position as president of the Baltimore Development Corp., I searched for evidence of the city’s technology scene.

There wasn’t much to see.

I first visited the BDC’s “incubator,” housed in an old — but not historic — building at 1444 Key Highway in South Baltimore. It was the only incubator in the region. As I met with the staff, I observed that several buckets had been strategically placed to catch water leaks (a seemingly insurmountable problem, as I was told).

Join us as we bring together the major players in Maryland’s startup ecosystem to celebrate entrepreneurism and award nearly $1,000,000 in prizes to the state’s most promising early-stage companies.

Who will win the Cyber, Life Sciences, IT and General Industry Categories? Join us May 19th to find out!

Sarah Bergbreiter is an assistant professor of mechanical engineering at the University of Maryland, and she and her team build tiny robots.

Just how tiny? Bergbreiter calls it “ant-scale,” but said, “That’s really just a PR term. Our robots are built on the millimetre scale, less than 1 centimeter.”

Horizon Pharma, Inc. today announced the appointment of H. Thomas Watkins, former director, president and chief executive officer of Human Genome Sciences, to its board of directors. Additionally, Jean-Francois Formela, M.D. has resigned from the Horizon board of directors.

“Tom brings valuable industry experience to our board as a highly regarded biotechnology leader,” said Timothy P. Walbert, chairman, president and chief executive officer, Horizon Pharma. “As we continue to grow our commercial business and build our organization through in-licensing and acquisitions, his strategic insights and pharmaceutical leadership experience will be important at this critical juncture for Horizon. Also, I would like to thank Jean-Francois for his years of service and counsel as a member of our board. Jean-Francois joined the Horizon board in 2010 in connection with our acquisition of Nitec and has been a valuable member of the board in helping us develop and implement the strategic direction of the Company.”

The Executive Director supports the Senior Advisor for Enterprise Development to the University President in directing and managing the short and long term critical priorities, initiatives and activities that relate to current entrepreneurship, commercialization, innovation, and translational efforts at Johns Hopkins University. The Executive Director represents the Senior Advisor to the President and ensures effective communication, coordination, and integration across various initiatives and programs where appropriate.